• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌肿瘤微环境及其对抗肿瘤免疫的影响:新疗法的未来展望。

Hepatocellular Carcinoma Tumor Microenvironment and Its Implications in Terms of Anti-tumor Immunity: Future Perspectives for New Therapeutics.

机构信息

Liver Transplant Institute and Faculty of Medicine Department of Surgery, Inonu University, Battalgazi, 44000, Malatya, Turkey.

出版信息

J Gastrointest Cancer. 2021 Dec;52(4):1198-1205. doi: 10.1007/s12029-021-00725-8. Epub 2021 Oct 8.

DOI:10.1007/s12029-021-00725-8
PMID:34625923
Abstract

PURPOSE

Hepatocellular cancer is an insidious tumor that is often diagnosed in a later stage of life. The tumor microenvironment is the key to tumorigenesis and progression. Many cellular and non-cellular components orchestrate the intricate process of hepatocarcinogenesis. The most important feature of hepatocellular cancer is the immune evasion process. The present review aims to summarize the key components of the tumor microenvironment in the immune evasion process.

METHODS

Google Scholar and PubMed databases have been searched for the mesh terms "Hepatocellular carcinoma" or "Liver Cancer" and "microenvironment." The articles were reviewed and the components of the tumor microenvironment were summarized.

RESULTS

The tumor microenvironment is composed of tumor cells and non-tumoral stromal and immune cells. HCC tumor microenvironment supports aggressive tumor behavior, provides immune evasion, and is an obstacle for current immunotherapeutic strategies. The components of the tumor microenvironment are intratumoral macrophages (tumor-associated macrophages (TAM)), bone marrow-derived suppressor cells, tumor-associated neutrophils (TAN), fibroblasts in the tumor microenvironment, and the activated hepatic stellate cells.

CONCLUSION

There are intricate mechanisms that drive hepatocarcinogenesis. The tumor microenvironment is at the center of all the complex and diverse mechanisms. Effective and multistep immunotherapies should be developed to target different components of the tumor microenvironment.

摘要

目的

肝细胞癌是一种隐匿性肿瘤,通常在生命的晚期被诊断出来。肿瘤微环境是肿瘤发生和进展的关键。许多细胞和非细胞成分共同调控着肝癌发生的复杂过程。肝细胞癌最重要的特征是免疫逃逸过程。本综述旨在总结肿瘤微环境在免疫逃逸过程中的关键成分。

方法

在 Google Scholar 和 PubMed 数据库中以“肝细胞癌”或“肝癌”和“微环境”为主题词进行搜索。对文章进行了回顾,并总结了肿瘤微环境的成分。

结果

肿瘤微环境由肿瘤细胞和非肿瘤性基质及免疫细胞组成。HCC 肿瘤微环境支持侵袭性肿瘤行为,提供免疫逃逸,并成为当前免疫治疗策略的障碍。肿瘤微环境的成分包括肿瘤内巨噬细胞(肿瘤相关巨噬细胞(TAM))、骨髓来源的抑制细胞、肿瘤相关中性粒细胞(TAN)、肿瘤微环境中的成纤维细胞和活化的肝星状细胞。

结论

有复杂的机制驱动肝癌的发生。肿瘤微环境是所有复杂和多样化机制的核心。应该开发有效的多步骤免疫疗法来针对肿瘤微环境的不同成分。

相似文献

1
Hepatocellular Carcinoma Tumor Microenvironment and Its Implications in Terms of Anti-tumor Immunity: Future Perspectives for New Therapeutics.肝细胞癌肿瘤微环境及其对抗肿瘤免疫的影响:新疗法的未来展望。
J Gastrointest Cancer. 2021 Dec;52(4):1198-1205. doi: 10.1007/s12029-021-00725-8. Epub 2021 Oct 8.
2
Components of the Hepatocellular Carcinoma Microenvironment and Their Role in Tumor Progression.肝细胞癌微环境的组成部分及其在肿瘤进展中的作用。
Biochemistry (Mosc). 2017 Aug;82(8):861-873. doi: 10.1134/S0006297917080016.
3
Tumor-Associated Macrophages in Hepatocellular Carcinoma: Friend or Foe?肝癌中的肿瘤相关巨噬细胞:是敌是友?
Gut Liver. 2021 Jul 15;15(4):500-516. doi: 10.5009/gnl20223.
4
Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities.当前对肝癌免疫抑制性肿瘤微环境的认识:挑战与机遇。
Mol Cancer. 2019 Aug 29;18(1):130. doi: 10.1186/s12943-019-1047-6.
5
Cellular prognostic markers in hepatocellular carcinoma.肝细胞癌中的细胞预后标志物
Future Oncol. 2015;11(11):1591-8. doi: 10.2217/fon.15.39.
6
The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets.肝细胞癌的肿瘤微环境:现状和治疗靶点。
Semin Cancer Biol. 2011 Feb;21(1):35-43. doi: 10.1016/j.semcancer.2010.10.007. Epub 2010 Oct 12.
7
Immune landscape of hepatocellular carcinoma microenvironment: Implications for prognosis and therapeutic applications.肝细胞癌微环境的免疫景观:对预后和治疗应用的影响。
Liver Int. 2019 Sep;39(9):1608-1621. doi: 10.1111/liv.14192. Epub 2019 Jul 28.
8
Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options.肝细胞癌的肿瘤微环境:新治疗方案面临的挑战与机遇
Int J Mol Sci. 2022 Mar 29;23(7):3778. doi: 10.3390/ijms23073778.
9
Systematic characterization of the tumor microenvironment in Chinese patients with hepatocellular carcinoma highlights intratumoral B cells as a potential immunotherapy target.系统分析中国肝癌患者的肿瘤微环境,突出肿瘤内 B 细胞作为潜在免疫治疗靶点。
Oncol Rep. 2022 Feb;47(2). doi: 10.3892/or.2021.8249. Epub 2021 Dec 27.
10
Role of the microenvironment in hepatocellular carcinoma development and progression.微环境在肝细胞癌发生和进展中的作用。
Cancer Treat Rev. 2012 May;38(3):218-25. doi: 10.1016/j.ctrv.2011.06.010. Epub 2011 Jul 16.

引用本文的文献

1
The role of immune regulation in HBV infection and hepatocellular carcinogenesis.免疫调节在乙肝病毒感染及肝细胞癌发生过程中的作用。
Front Immunol. 2025 Mar 14;16:1506526. doi: 10.3389/fimmu.2025.1506526. eCollection 2025.
2
MRI Coregistered Rodent Histotripsy Array for Orthotopic Liver Models.用于原位肝模型的磁共振成像(MRI)配准啮齿动物组织粉碎阵列
IEEE Trans Ultrason Ferroelectr Freq Control. 2025 May;72(5):581-590. doi: 10.1109/TUFFC.2025.3553083. Epub 2025 May 7.
3
Bidirectional role of neutrophils in tumor development.中性粒细胞在肿瘤发展中的双向作用。

本文引用的文献

1
Hepatic microenvironment underlies fibrosis in chronic hepatitis B patients.慢性乙型肝炎患者的肝微环境是纤维化的基础。
World J Gastroenterol. 2020 Jul 21;26(27):3917-3928. doi: 10.3748/wjg.v26.i27.3917.
2
Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities.当前对肝癌免疫抑制性肿瘤微环境的认识:挑战与机遇。
Mol Cancer. 2019 Aug 29;18(1):130. doi: 10.1186/s12943-019-1047-6.
3
The Intersection between Tumor Angiogenesis and Immune Suppression.肿瘤血管生成与免疫抑制的交集。
Mol Cancer. 2025 Jan 16;24(1):22. doi: 10.1186/s12943-025-02228-7.
4
Role of Epigenetic Factors in Determining the Biological Behavior and Prognosis of Hepatocellular Carcinoma.表观遗传因素在决定肝细胞癌生物学行为和预后中的作用
Diagnostics (Basel). 2024 Aug 31;14(17):1925. doi: 10.3390/diagnostics14171925.
5
Single-Cell RNA Sequencing Identifies Crucial Genes Influencing the Polarization of Tumor-Associated Macrophages in Liver Cancer.单细胞RNA测序鉴定影响肝癌中肿瘤相关巨噬细胞极化的关键基因。
Int J Genomics. 2024 May 25;2024:7263358. doi: 10.1155/2024/7263358. eCollection 2024.
6
Strategies and Recent Advances on Improving Efficient Antitumor of Lenvatinib Based on Nanoparticle Delivery System.基于纳米递药系统提高仑伐替尼抗肿瘤效率的策略及研究进展。
Int J Nanomedicine. 2024 Jun 10;19:5581-5603. doi: 10.2147/IJN.S460844. eCollection 2024.
7
Characterization of m6A methylation modifications in gastric cancer.胃癌中 m6A 甲基化修饰的特征。
Aging (Albany NY). 2024 Jan 10;16(1):89-105. doi: 10.18632/aging.205341.
8
Single-cell and genetic multi-omics analysis combined with experiments confirmed the signature and potential targets of cuproptosis in hepatocellular carcinoma.单细胞和基因多组学分析结合实验证实了肝细胞癌中铜死亡的特征和潜在靶点。
Front Cell Dev Biol. 2023 Sep 8;11:1240390. doi: 10.3389/fcell.2023.1240390. eCollection 2023.
9
Progress in research on tumor microenvironment-based spatial omics technologies.基于肿瘤微环境的空间组学技术研究进展。
Oncol Res. 2023 Sep 15;31(6):877-885. doi: 10.32604/or.2023.029494. eCollection 2023.
10
Multiple Roles of LOXL2 in the Progression of Hepatocellular Carcinoma and Its Potential for Therapeutic Targeting.LOXL2 在肝细胞癌进展中的多重作用及其作为治疗靶点的潜力。
Int J Mol Sci. 2023 Jul 21;24(14):11745. doi: 10.3390/ijms241411745.
Clin Cancer Res. 2019 Sep 15;25(18):5449-5457. doi: 10.1158/1078-0432.CCR-18-1543. Epub 2019 Apr 3.
4
Bone morphogenetic protein 4 provides cancer-supportive phenotypes to liver fibroblasts in patients with hepatocellular carcinoma.骨形态发生蛋白 4 为肝癌患者的肝成纤维细胞提供了支持癌症的表型。
J Gastroenterol. 2019 Nov;54(11):1007-1018. doi: 10.1007/s00535-019-01579-5. Epub 2019 Apr 2.
5
Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer.肿瘤相关巨噬细胞作为浸润性乳腺癌潜在的预后生物标志物
J Breast Cancer. 2019 Mar;22(1):38-51. doi: 10.4048/jbc.2019.22.e5.
6
A Positive Feedback Loop Between Cancer Stem-Like Cells and Tumor-Associated Neutrophils Controls Hepatocellular Carcinoma Progression.肿瘤相关中性粒细胞与肿瘤干细胞之间的正反馈环控制肝癌进展。
Hepatology. 2019 Oct;70(4):1214-1230. doi: 10.1002/hep.30630. Epub 2019 May 15.
7
Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion.巨噬细胞衍生的 CCL22 通过 IL-8 在恶性胸腔积液中促进免疫抑制性肿瘤微环境。
Cancer Lett. 2019 Jun 28;452:244-253. doi: 10.1016/j.canlet.2019.03.040. Epub 2019 Mar 27.
8
Targeting immune cells for cancer therapy.针对免疫细胞的癌症疗法。
Redox Biol. 2019 Jul;25:101174. doi: 10.1016/j.redox.2019.101174. Epub 2019 Mar 20.
9
Targeting Tumor-Associated Macrophages in Cancer.靶向肿瘤相关巨噬细胞治疗癌症。
Trends Immunol. 2019 Apr;40(4):310-327. doi: 10.1016/j.it.2019.02.003. Epub 2019 Mar 17.
10
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape.肿瘤微环境在 PD-L1/PD-1 介导的肿瘤免疫逃逸中的作用。
Mol Cancer. 2019 Jan 15;18(1):10. doi: 10.1186/s12943-018-0928-4.